elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37006130-1EC72595-D6F8-4B78-A576-D9087B5667AF
Q37006130-1EC72595-D6F8-4B78-A576-D9087B5667AF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37006130-1EC72595-D6F8-4B78-A576-D9087B5667AF
Interaction of tRNA with MEK2 in pancreatic cancer cells
P2860
Q37006130-1EC72595-D6F8-4B78-A576-D9087B5667AF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37006130-1EC72595-D6F8-4B78-A576-D9087B5667AF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c493bd825a2ec76163742d31877caf068253275f
P2860
A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas.